查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790344

美国解剖病理学市场规模、份额和趋势分析报告（按产品/服务、应用、最终用途和细分市场预测，2025 年至 2030 年）

U.S. Anatomic Pathology Market Size, Share & Trends Analysis Report By Product & Services (Instruments, Consumables, Services), By Application (Disease Diagnosis, Drug Discovery & Development), By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国解剖病理学市场概况

美国解剖病理学市场规模预计在 2024 年为 97.1 亿美元，预计到 2030 年将达到 153.5 亿美元，2025 年至 2030 年的复合年增长率为 7.1%。在技术创新和不断增长的临床需求的推动下，该市场正在经历强劲增长。

在分析前、分析中和分析后等所有阶段整合自动化和数位化解决方案，是提高诊断准确性、效率和患者预后的关键。先进病理学设备（包括大体成像系统、数位显微镜和自动染色平台）的日益集成，有望提升解剖病理学实践。

尤其是数位成像技术，与传统方法相比，显着提高了诊断的特异性和准确性。因此，由于对更准确、更可靠的诊断服务的需求不断增长，解剖病理学市场正在迅速采用这些数位解决方案。 2023年3月，PathAI, Inc. 推出了 AISight 数位病理平台和 AIM-PD-L1 NSCLC RUO 演算法。 13个主要的医疗系统、学术医疗中心、独立病理组织和参考实验室参与了 AISight 早期访问计划。

美国个人化医疗和精准医疗的发展极大地推动了对解剖病理学服务的需求。随着治疗方案越来越针对患者的个别基因和分子特征进行量身定制，准确而详细的组织分析至关重要。解剖病理学家发挥核心作用，他们对活检和手术标本进行专门检测，包括免疫组织化学 (IHC)、原位杂合反应和次世代定序(NGS)，以检测重要的生物标誌物，例如切片检查、EGFR 、KRAS 和检体。这些结果直接指导乳癌、肺癌和大肠直肠癌标靶治疗的选择。

美国解剖病理学市场细分

本报告预测了2018年至2030年各国各国的收益成长，并分析了每个细分领域的最新行业趋势。在本研究中，Grand View Research, Inc. 根据产品/服务、应用和最终用途对美国解剖病理学市场报告进行了细分。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国解剖病理学市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国解剖病理学市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析
  • 美国解剖病理学市场：通路分析

第四章美国解剖病理学市场：按产品和服务的估计和趋势分析

  • 产品和服务细分仪表板
  • 美国解剖病理学市场：产品与服务差异分析
  • 2018 年至 2030 年美国解剖病理学市场规模及趋势分析（依产品及服务）
  • 装置
    • 切片机和低温恒温器切片机
    • 组织处理器
    • 自动过滤器
    • 全幻灯片成像（WSI）扫描仪
    • 其他的
  • 耗材
    • 试剂和抗体
    • 探针和套件
    • 其他的
  • 服务

第五章美国解剖病理学市场的应用、估计与趋势分析

  • 应用程式细分仪表板
  • 美国解剖病理学市场：应用变异分析
  • 2018-2030年美国解剖病理学市场规模及应用趋势分析
  • 疾病诊断
  • 药物研发
  • 其他的

第六章美国解剖病理学市场最终用途、估计与趋势分析

  • 最终用途细分仪表板
  • 美国解剖病理学市场：最终用途变异分析
  • 2018-2030 年美国解剖病理学市场规模及趋势分析（依最终用途）
  • 医院
  • 实验室
  • 诊断实验室
  • 其他的

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 2024年主要企业热图分析
  • 公司简介
    • Danaher Corporation
    • Quest Diagnostics Incorporated
    • Labcorp
    • Agilent Technologies, Inc.
    • Cardinal Health
    • Sakura Finetek USA, Inc.
    • NeoGenomics Laboratories, Inc.
    • BioGenex
    • Bio SB
Product Code: GVR-4-68040-664-2

U.S. Anatomic Pathology Market Summary

The U.S. anatomic pathology market size was estimated at USD 9.71 billion in 2024 and is projected to reach USD 15.35 billion by 2030, growing at a CAGR of 7.1% from 2025 to 2030. This market is experiencing robust growth driven by technological innovation and growing clinical demands.

Integrating automation and digital solutions across all phases, such as pre-analytical, analytical, and post-analytical, is key to enhancing diagnostic accuracy, efficiency, and patient outcomes. The growing integration of advanced pathology equipment, such as gross imaging systems, digital microscopes, and automated staining platforms, is poised to enhance anatomic pathology practices.

Digital imaging technologies, in particular, deliver notable improvements in diagnostic specificity and accuracy over traditional methods. Consequently, the market for anatomic pathology is witnessing a surge in the adoption of these digital solutions, fueled by rising demand for diagnostic services that offer greater precision and reliability. In March 2023, PathAI, Inc. launched its AISight digital pathology platform and AIM-PD-L1 NSCLC RUO algorithm. Thirteen leading health systems, academic medical centers, and independent pathology organizations and reference laboratories participated in AISight Early Access Program.

The growth of personalized and precision medicine in the U.S. significantly fuels demand for anatomic pathology services. Accurate and detailed tissue analysis has become essential as more treatments become tailored to a patient's individual genetic and molecular profile. Anatomic pathologists play a central role by performing specialized testing on biopsy and surgical specimens-including immunohistochemistry (IHC), in situ hybridization, and next-generation sequencing (NGS)-to detect key biomarkers such as HER2, EGFR, KRAS, and PD-L1. These results directly guide the selection of targeted therapies in breast, lung, and colorectal cancers.

U.S. Anatomic Pathology Market Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. anatomic pathology market report based on product & services, application, and end use.

  • Product & Services Outlook (Revenue, USD Billion, 2018 - 2030)
  • Instruments
    • Microtomes & Cryostat microtomes
    • Tissue processors
    • Automatic strainers
    • Whole Slide Imaging (WSI) Scanners
    • Other products
  • Consumables
    • Reagents & Antibodies
    • Probes & Kits
    • Others
  • Services
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Disease Diagnosis
  • Drug Discovery and Development
  • Others
  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product & services outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Anatomic Pathology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Anatomic Pathology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. U.S. Anatomic Pathology Market: Pipeline Analysis

Chapter 4. U.S. Anatomic Pathology Market: Product & Services Estimates & Trend Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. U.S. Anatomic Pathology Market: Product & Services Movement Analysis
  • 4.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Billion)
  • 4.4. Instruments
    • 4.4.1. Microtomes & Cryostat microtomes
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.4.2. Tissue processors
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.4.3. Automatic strainers
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.4.4. Whole Slide Imaging (WSI) Scanners
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.4.5. Other products
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD billion)
  • 4.5. Consumables
    • 4.5.1. Reagents & Antibodies
      • 4.5.1.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.5.2. Probes & Kits
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.5.3. Others
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD billion)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Anatomic Pathology Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Anatomic Pathology Market: Application Movement Analysis
  • 5.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 5.4. Disease Diagnosis
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Drug Discovery and Development
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Others
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. Anatomic Pathology Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. U.S. Anatomic Pathology Market: End Use Movement Analysis
  • 6.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Research Laboratories
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Diagnostic Laboratories
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.7. Others
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Danaher Corporation
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Quest Diagnostics Incorporated
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Labcorp
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Agilent Technologies, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Cardinal Health
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Sakura Finetek USA, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. NeoGenomics Laboratories, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. BioGenex
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Bio SB
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. anatomic pathology market, by product & services, 2018 - 2030 (USD Billion)
  • Table 3 U.S. anatomic pathology market, by application, 2018 - 2030 (USD Billion)
  • Table 4 U.S. anatomic pathology market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. anatomic pathology market: market outlook
  • Fig. 10 U.S. anatomic pathology competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. anatomic pathology market driver impact
  • Fig. 16 U.S. anatomic pathology market restraint impact
  • Fig. 17 U.S. anatomic pathology market strategic initiatives analysis
  • Fig. 18 U.S. anatomic pathology market: Product & services movement analysis
  • Fig. 19 U.S. anatomic pathology market: Product & services outlook and key takeaways
  • Fig. 20 Instruments market estimates and forecasts, 2018 - 2030
  • Fig. 21 Microtomes & cryostat microtomes market estimates and forecasts, 2018 - 2030
  • Fig. 22 Tissue processors market estimates and forecasts, 2018 - 2030
  • Fig. 23 Automatic strainers market estimates and forecasts, 2018 - 2030
  • Fig. 24 Whole Slide Imaging (WSI) scanners market estimates and forecasts, 2018 - 2030
  • Fig. 25 Other products market estimates and forecasts, 2018 - 2030
  • Fig. 26 Consumables market estimates and forecasts, 2018 - 2030
  • Fig. 27 Reagents & antibodies market estimates and forecasts, 2018 - 2030
  • Fig. 28 Probes & kits market estimates and forecasts, 2018 - 2030
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030
  • Fig. 30 Services market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. anatomic pathology market: Application movement analysis
  • Fig. 32 U.S. anatomic pathology market: Application outlook and key takeaways
  • Fig. 33 Disease diagnosis market estimates and forecasts, 2018 - 2030
  • Fig. 34 Drug discovery and development market estimates and forecasts, 2018 - 2030
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030
  • Fig. 36 U.S. anatomic pathology market: End use movement analysis
  • Fig. 37 U.S. anatomic pathology market: End use outlook and key takeaways
  • Fig. 38 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 39 Research laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 40 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030